Evidence map›Paper›PMID 22479149›Full record

ArticlePLoS biology2012

Mediator acts upstream of the transcriptional activator Gal4.

Keven Ang, Gary Ee, Edwin Ang, Elvin Koh, Wee Leng Siew, Yu Mun Chan, Sabrina Nur, Yee Sun Tan, Norbert Lehming

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Monitoring of switches in heterochromatin-induced silencing shows incomplete establishment and developmental instabilities.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  4. Review
  5. Article
  6. Cytosolic Hsp60 can modulate proteasome activity in yeast.The Journal of biological chemistry · 2015
    Article
  7. Review
  8. Article
  9. Article
  10. Mechanisms of Mediator complex action in transcriptional activation.Cellular and molecular life sciences : CMLS · 2013
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Keven AngDepartment of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Gary Ee
Edwin Ang
Elvin Koh
Wee Leng Siew
Yu Mun Chan
Sabrina Nur
Yee Sun Tan
Norbert Lehming
National University of Singapore · SGUniversity of Massachusetts Chan Medical School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proteasome inhibitor MG132 had been shown to prevent galactose induction of the S. cerevisiae GAL1 gene, demonstrating that ubiquitin proteasome-dependent degradation of transcription factors plays an important role in the regulation of gene expression. The deletion of the gene encoding the F-box protein Mdm30 had been reported to stabilize the transcriptional activator Gal4 under inducing conditions and to lead to defects in galactose utilization, suggesting that recycling of Gal4 is required for its function. Subsequently, however, it was argued that Gal4 remains stably bound to the enhancer under inducing conditions, suggesting that proteolytic turnover of Gal4 might not be required for its function. We have performed an alanine-scanning mutagenesis of ubiquitin and isolated a galactose utilization-defective ubiquitin mutant. We have used it for an unbiased suppressor screen and identified the inhibitor Gal80 as a suppressor of the transcriptional defects of the ubiquitin mutant, indicating that the protein degradation of the inhibitor Gal80, and not of the activator Gal4, is required for galactose induction of the GAL genes. We also show that in the absence of Gal80, Mdm30 is not required for Gal4 function, strongly supporting this hypothesis. Furthermore, we have found that Mediator controls the galactose-induced protein degradation of Gal80, which places Mediator genetically upstream of the activator Gal4. Mediator had originally been isolated by its ability to respond to transcriptional activators, and here we have discovered a leading role for Mediator in the process of transcription. The protein kinase Snf1 senses the inducing conditions and transduces the signal to Mediator, which initiates the degradation of the inhibitor Gal80 with the help of the E3 ubiquitin ligase SCF(Mdm30). The ability of Mediator to control the protein degradation of transcriptional inhibitors indicates that Mediator is actually able to direct its own recruitment to gene promoters.

Indexed as

Transcriptional ActivationCulture MediaCyclinsDNA-Binding ProteinsF-Box ProteinsGalactoseGene DeletionGene Expression Regulation, FungalGenes, FungalHeLa CellsHumansImmunoprecipitationMediator ComplexPromoter Regions, GeneticProtein BindingProtein StabilityCulture MediaCyclinsDNA-Binding ProteinsF-Box ProteinsGAL4 protein, S cerevisiaeGAL80 protein, S cerevisiaeGalactoseMdm30 protein, S cerevisiaeMED21 protein, humanMediator ComplexRepressor ProteinsSaccharomyces cerevisiae ProteinsSKP1 protein, humanS-Phase Kinase-Associated ProteinsSSN8 protein, S cerevisiaeTranscription FactorsUbiquitin

Identifiers

PMID22479149
PMCPMC3313914
OpenAlexW2035885463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.